Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7838]

Research spotlight: Identifying potential new protein targets for melanoma therapeutics

Research spotlight: Identifying potential new protein targets for melanoma therapeutics

FDA approves new therapy for glioma patients for first time in decades

FDA approves new therapy for glioma patients for first time in decades

New hope for prostate cancer: new form of immunotherapy could prevent resistance to hormone therapy

New hope for prostate cancer: new form of immunotherapy could prevent resistance to hormone therapy

Improved chemokine homing enhances CAR T–cell therapy for osteosarcoma

Improved chemokine homing enhances CAR T–cell therapy for osteosarcoma

Circular RNAs – the new frontier in cancer research

Circular RNAs – the new frontier in cancer research

NETO2 promotes melanoma progression via activation of the Ca2+/CaMKII signalling pathway

NETO2 promotes melanoma progression via activation of the Ca2+/CaMKII signalling pathway

FDA approves daratumumab and hyaluronidase-fihj with bortezomib, lenalidomide, and dexamethasone for multiple myeloma

FDA approves daratumumab and hyaluronidase-fihj with bortezomib, lenalidomide, and dexamethasone for multiple...

FDA grants accelerated approval to afamitresgene autoleucel for unresectable or metastatic synovial sarcoma

FDA grants accelerated approval to afamitresgene autoleucel for unresectable or metastatic synovial sarcoma

New findings on possible therapies to target oncogenic transcription factors in multiple cancer types

New findings on possible therapies to target oncogenic transcription factors in multiple cancer types

Preclinical study explores approved drug for ovarian cancer

Preclinical study explores approved drug for ovarian cancer

More from ecancer